|
Publikationer
|
|
dok
|
Dansk geriatrisk forskning 1990- |
 |
K. Andersen-Ranberg, K. Christensen, B. Jejune, A. Skytthe, L. Vasegaard, and J. W. Vaupel. Declining physical abilities with age: a cross-sectional study of older twins and centenarians in Denmark. Age and Ageing 28:373-377, 1999.
PubMed
|
|
 |
K. Andersen-Ranberg, M. Schroll, and B. Jeune Healthy centenarians do not exist, but autonomous do: A population-based study of morbidity among Danish centenarians. J Am Geriatr Soc 49:900-908, 2001.
|
|
 |
K. Andersen-Ranberg, M. Schroll, and B. Jeune. Healthy centenarians do not exist, but autonomous do: A population-based study of morbidity among Danish centenarians J Am Geriatr Soc 49:900-908, 2001
|
|
 |
K. Avlund, B. E. Holstein, E. L. Mortensen, and M. Schroll. Active life in old age. Combining measures of functional ability and social participation Dan Med Bull 46:345, 1999.
PubMed
|
|
 |
K. Avlund, D. Thudium, M. Davidsen, and B. Fuglsang-Sørensen. Are self-ratings of functional ability reliable? Scandinavian J of Occupational Therapy 2:10-16, 1995.
|
|
 |
K. Avlund, M. Osler, M. Trab, U. Christensen, and M. Schroll. The relations between musculoskeletal diseases and mobility among old people: Are they influenced by socio-economic, psychosocial and behavioral factors? International J of Behavioral Medicine 4:322-339 2000.
|
|
 |
K. Avlund, R. L. Heikkinen, and M. Schroll. Social relations and functional ability. A comparative study of 75-year-old men and women in three Nordic localities. Serdi Publisher:27-40, 1997.
|
|
 |
K. Brøsen and E. Skjelbo. Fluoxetine and norfluoxetine are potent inhibitors of P450IID6 - the source of the spanteine/debrisoquine oxidation polymorphism Br J Clin Pharrmacol 32:138-137, 1991.
PubMed
|
|
 |
K. Brøsen, E. Skjelbo, and H. Flachs. Proguanil metabolism is determined by the mephenytoin oxidation polymorphism in Vietnamese living in Denmark Br J Clin Pharrmacol 36:105-108, 1993.
PubMed
|
|
 |
K. Brøsen, E. Skjelbo, B. B. rasmussen, H. E. Poulsen, and S. Loft. Fluvoxamine is a very potent inhibitor of cytochrome P4501A2. Biochem Pharmacol 45:1211-1214, 1993.
PubMed
|
|
|
|
|